A detailed history of Geode Capital Management, LLC transactions in Vanda Pharmaceuticals Inc. stock. As of the latest transaction made, Geode Capital Management, LLC holds 1,425,827 shares of VNDA stock, worth $7.26 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,425,827
Previous 1,330,957 7.13%
Holding current value
$7.26 Million
Previous $7.52 Million 11.07%
% of portfolio
0.0%
Previous 0.0%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$4.61 - $6.34 $437,350 - $601,475
94,870 Added 7.13%
1,425,827 $6.69 Million
Q2 2024

Aug 09, 2024

BUY
$3.91 - $6.5 $334,598 - $556,237
85,575 Added 6.87%
1,330,957 $7.52 Million
Q1 2024

May 13, 2024

SELL
$3.47 - $4.61 $419 - $557
-121 Reduced 0.01%
1,245,382 $5.12 Million
Q4 2023

Feb 13, 2024

BUY
$3.38 - $4.58 $223,918 - $303,415
66,248 Added 5.62%
1,245,503 $5.26 Million
Q3 2023

Nov 13, 2023

BUY
$4.28 - $6.57 $189,736 - $291,254
44,331 Added 3.91%
1,179,255 $5.09 Million
Q2 2023

Aug 11, 2023

BUY
$5.9 - $6.95 $309,118 - $364,131
52,393 Added 4.84%
1,134,924 $7.48 Million
Q1 2023

May 15, 2023

BUY
$6.18 - $7.99 $185,035 - $239,228
29,941 Added 2.84%
1,082,531 $7.35 Million
Q4 2022

Feb 13, 2023

BUY
$6.87 - $10.96 $179,148 - $285,803
26,077 Added 2.54%
1,052,590 $7.78 Million
Q3 2022

Nov 14, 2022

BUY
$9.44 - $11.76 $88,216 - $109,897
9,345 Added 0.92%
1,026,513 $10.1 Million
Q2 2022

Aug 12, 2022

BUY
$9.31 - $11.84 $44,008 - $55,967
4,727 Added 0.47%
1,017,168 $11.1 Million
Q1 2022

May 13, 2022

SELL
$10.84 - $16.55 $160,616 - $245,221
-14,817 Reduced 1.44%
1,012,441 $11.5 Million
Q4 2021

Feb 11, 2022

BUY
$15.69 - $21.14 $259,732 - $349,951
16,554 Added 1.64%
1,027,258 $16.1 Million
Q3 2021

Nov 12, 2021

BUY
$15.35 - $21.27 $97,349 - $134,894
6,342 Added 0.63%
1,010,704 $17.3 Million
Q2 2021

Aug 13, 2021

BUY
$15.71 - $21.51 $611,873 - $837,771
38,948 Added 4.03%
1,004,362 $21.6 Million
Q1 2021

May 12, 2021

BUY
$13.42 - $20.28 $1.53 Million - $2.31 Million
113,991 Added 13.39%
965,414 $14.5 Million
Q4 2020

Feb 12, 2021

BUY
$9.77 - $13.81 $328,086 - $463,753
33,581 Added 4.11%
851,423 $11.2 Million
Q3 2020

Nov 13, 2020

BUY
$9.32 - $12.02 $111,131 - $143,326
11,924 Added 1.48%
817,842 $7.9 Million
Q2 2020

Aug 13, 2020

BUY
$9.66 - $12.02 $422,074 - $525,189
43,693 Added 5.73%
805,918 $9.22 Million
Q1 2020

May 14, 2020

BUY
$7.5 - $16.8 $12,472 - $27,938
1,663 Added 0.22%
762,225 $7.9 Million
Q4 2019

Feb 13, 2020

BUY
$12.38 - $17.47 $41,138 - $58,052
3,323 Added 0.44%
760,562 $12.5 Million
Q3 2019

Nov 12, 2019

BUY
$12.27 - $15.79 $360,173 - $463,499
29,354 Added 4.03%
757,239 $10.1 Million
Q2 2019

Aug 14, 2019

BUY
$13.37 - $18.85 $1.19 Million - $1.67 Million
88,791 Added 13.89%
727,885 $10.3 Million
Q1 2019

May 14, 2019

BUY
$17.59 - $31.05 $747,012 - $1.32 Million
42,468 Added 7.12%
639,094 $11.8 Million
Q4 2018

Feb 13, 2019

BUY
$18.97 - $31.47 $126,454 - $209,779
6,666 Added 1.13%
596,626 $15.6 Million
Q3 2018

Nov 13, 2018

BUY
$18.25 - $23.0 $456,980 - $575,920
25,040 Added 4.43%
589,960 $13.5 Million
Q2 2018

Aug 14, 2018

BUY
$13.95 - $19.15 $889,647 - $1.22 Million
63,774 Added 12.73%
564,920 $10.8 Million
Q1 2018

May 15, 2018

BUY
$14.05 - $20.2 $1.43 Million - $2.06 Million
102,100 Added 25.59%
501,146 $8.44 Million
Q4 2017

Feb 13, 2018

SELL
$12.85 - $18.1 $346,924 - $488,663
-26,998 Reduced 6.34%
399,046 $6.07 Million
Q3 2017

Nov 14, 2017

SELL
$15.4 - $18.85 $92,554 - $113,288
-6,010 Reduced 1.39%
426,044 $7.63 Million
Q2 2017

Aug 14, 2017

BUY
N/A
432,054
432,054 $7.04 Million

Others Institutions Holding VNDA

About Vanda Pharmaceuticals Inc.


  • Ticker VNDA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 56,561,500
  • Market Cap $288M
  • Description
  • Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs. The company's marketed products include HETLIOZ for the treatment of non-24-hour sleep-wake disorders; and Fanapt oral tablets for the treatment of schizophrenia. Its products under developme...
More about VNDA
Track This Portfolio

Track Geode Capital Management, LLC Portfolio

Follow Geode Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.